Deals
Teleflex Is in Talks to Buy German Biotronik’s Stent Unit
- Teleflex is offering to buy business for at least €500 million
- An agreement could be reached this month if talks go smoothly
A coronary vessel with a stent
Photographer: Mark Abraham/Bloomberg News
This article is for subscribers only.
Teleflex Inc. is in discussions to acquire German medical technology firm Biotronik SE & Co.’s vascular intervention unit, according to people familiar with the matter.
Teleflex is offering to buy the Biotronik business for €500 million ($526 million) to €1 billion, said the people, who asked not to be identified as the information is private. An agreement could be reached as soon as this month, another person said.